Genetische Analysen zur Identifizierung molekularer Mechanismen bei Autismus-Spektrum-Störungen
Abstract
Autismus-Spektrum-Störungen (ASS) sind neuronale Entwicklungsstörungen mit Auswirkung auf Kommunikation, Sprachentwicklung und Verhalten. Der komplexe Phänotyp und die starke klinische Heterogenität lassen bei erhöhter Disposition von ASS unter Geschwistern auf einen multifaktoriellen genetischen Hintergrund schließen. Neben einzelnen seltenen Mutationen werden auch Genkopie-Varianten und Einzelnukleotid-Polymorphismen immer mehr als Risikofaktoren in Betracht gezogen. Zur Identifizierung zentraler Schlüsselmechanismen werden im Rahmen von Konsortien Kopplungsanalysen und genomweite Assoziationsstudien durchgeführt. Außer polygenen bzw. genetisch komplexen Modellen, denen ASS zugrunde liegt, gibt es auch monogenetisch bedingte Formen. Dabei kommt es durch Aberrationen an einzelnen Genen zu einem autistischen Phänotyp, wie z. B. beim Fragilen-X-Syndrom. Knockout-Tiermodelle für monogenetischen Autismus wie FMRP–/– oder für neurodegenerative Erkrankungen wie MeCP2–/– werden häufig zur Untersuchung der molekularen Mechanismen herangezogen, welche bei ASS gestört sein könnten. Hier geben wir einen Einblick in den Stand der aktuellen Forschung im Bereich der Genomanalyse und beschreiben die wichtigsten Mausmodelle im Hinblick auf die Erkenntnisse bei poly- und monogenetischem Autismus. Grundsätzlich kann man erkennen, dass die meisten assoziierten Genomregionen und Gene im Zusammenhang mit der Ausbildung des synaptischen Spalts, der korrekten Sekretion von Oberflächenmolekülen oder der Translation stehen. Dies lässt vermuten, dass der Phänotyp bei ASS vorrangig durch eine Störung der translationsabhängigen Zell-Zell-Konnektivität und synaptischen Plastizität hervorgerufen wird.
Autism spectrum disorders (ASD) are severe neurodevelopmental disorders with marked deficits in social communication, verbal development, and behaviour. The broad phenotype and the clinical heterogeneity point to a polygenic disorder – despite high heritability among siblings. According to recent findings not only do single-rare mutations but also copy number variations and single nucleotide polymorphisms impact the ASD phenotype. Because of the scope of national and international consortia, many linkage and genome-wide association studies have evolved which elucidate candidate and susceptibility genomic regions and genes relevant for ASD. In contrast to polygenic or genetic complex models for autism, a few monogenetic forms of ASD are known to be caused by single gene defects, e.g., fragile-X syndrome. Knock-out animal models of monogenetic autism (e.g. FMRP–/–) or neurodegenerative disorders (e.g. MeCP2–/–) are often used to analyze the molecular mechanisms underlying ASD. In this review we describe the state of the art of genome analyses in ASD, the most widely used mouse models for polygenic or monogenetic forms of autism and discuss new insights gained from these analyses. The susceptibility genes so far identified seem to be involved in the proper establishment of the synaptic cleft, the secretion of surface proteins, or the overall cellular translation processes. Theses findings suggest that impacting translation-dependent processes like synaptic plasticity or cell-to-cell connectivity may lead to an ASD phenotype.
Literatur
2008). Advances in autism genetics: On the threshold of a new neurobiology. Nature Reviews Genetics, 9, 341–355.
(2008). Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. American Journal of Human Genetics, 82, 150–159.
(2008). A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. American Journal of Human Genetics, 82, 160–164.
(1944). Die autistischen Psychopathen im Kindesalter. Archiv Psychiatrischer Nervenkrankheiten, 117, 76–136.
(1995). Autism as a strongly genetic disorder: Evidence from a british twin study. Psychological Medicine, 25, 63–77.
(2008). Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. American Journal of Human Genetics, 82, 165–173.
(2009). The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders. Trends in Neuroscience, 32, 402–412.
(2009). Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genetics, 5, e1000536.
(2008). Copy-number variations associated with neuropsychiatric conditions. Nature, 455, 919–923.
W. (2007). Mouse behavioral assays relevant to the symptoms of autism. Brain Pathology, 17, 448–459.
(2009). Genetics and neuropsychiatric disorders: Genome-wide, yet narrow. Nature Medicine, 15, 850–851.
(2010). Rare variants create synthetic genome-wide associations. PLoS Biology, 8, e1000294.
(2000). Fmr1 knockout mouse has a distinctive strain-specific learning impairment. Neuroscience, 100, 423–429.
(2007). Correction of fragile X syndrome in mice. Neuron, 56, 955–962.
(2007). Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nature Genetics, 39, 25–27.
(2006). High frequency of neurexin 1beta signal peptide structural variants in patients with autism. Neuroscience Letters, 409, 10–13.
(2007). The genetics of autistic disorders and its clinical relevance: A review of the literature. Molecular Psychiatry, 12, 2–22.
(2007). New models of collaboration in genome-wide association studies: The Genetic Association Information Network. Nature Genetics, 39, 1045–1051.
. (2009). Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature, 459, 569–573.
(2005). The autism genome project: Goals and strategies. American Journal of Pharmacogenomics, 5, 233–246.
(2002). Influence of mutation type and location on phenotype in 123 patients with Rett Syndrome. Neuropediatrics, 33, 63–68.
(1998). A full genome screen for autism with evidence for linkage to a region on chromosome 7q. Human Molecular Genetics, 7, 571–578.
. (2001a). Further characterization of the autism susceptibility locus auts1 on chromosome 7q. Human Molecular Genetics, 10, 973–982.
. (2001b). A genomewide screen for autism: Strong evidence for linkage to chromosomes 2q, 7q, and 16p. American Journal of Human Genetics, 69, 570–581.
. (2003). Mutations of the x-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nature Genetics, 34, 27–29.
(2004). Biochemical and genetic interaction between the Fragile X Mental Retardation protein and the microRNA pathway. Nature Neuroscience, 7, 113–117.
(1943). Autistic disturbances of affective contact. The Nervous Child, 2, 270–250.
(1999). Grc5 and nmd3 function in translational control of gene expression and interact genetically. Current Genetics, 34, 419–429.
(2008). The autistic neuron: Troubled translation? Cell, 135, 401–406.
(2004). Translational control by MAPK signaling in long-term synaptic plasticity and memory. Cell, 116, 467–479.
(2008). Association of DISC1 with autism and Asperger syndrome. Molecular Psychiatry, 13, 187–196.
(2008). Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Human Molecular Genetics, 17, 458–465.
(2006). Genetics of autism spectrum disorder. European Journal of Human Genetics, 14, 714–720.
(2006). Mutations in the ribosomal protein gene RPL10 suggest a novel modulating disease mechanism for autism. Molecular Psychiatry, 11, 1073–1084.
(2006). The systematic functional characterisation of Xq28 genes prioritises candidate disease genes. BMC Genomics, 7, 29.
(1996). The yeast growth control gene GRC5 is highly homologous to the mammalian putative tumor suppressor gene QM. Yeast, 12, 53–65.
(2007). Knock-in of mutant k-ras in nontumorigenic human epithelial cells as a new model for studying k-ras mediated transformation. Cancer Research, 67, 8460–8467.
(2009). Association and mutation analyses of 16p11.2 autism candidate genes. PLoS One, 4, e4582.
(2005). Effects of familial risk factors and place of birth on the risk of autism: A nationwide register-based study. The Journal of Child Psychology and Psychiatry, 46, 963–971.
(2008). Genome-wide linkage analyses of quantitative and categorical autism subphenotypes. Biological Psychiatry, 64, 561–570.
. (2008). Genome-wide association studies for complex traits: Consensus, uncertainty and challenges. Nature Reviews in Genetics, 9, 356–369.
(2007). Contribution of SHANK3 mutations to autism spectrum disorder. American Journal of Human Genetics, 81, 1289–1297.
(2008). Identifying autism loci and genes by tracing recent shared ancestry. Science, 321, 218–223.
(2006). Mouse models of autism spectrum disorders: The challenge for behavioral genetics. American Journal of Medical Genetics, Part C(142C), 40–51.
(2003). Translational regulator RPL10p/GRC5p interacts physically and functionally with SED1p, a dynamic component of the yeast cell surface. Yeast, 20, 281–294.
(2005). Evolution and functional classification of vertebrate gene deserts. Genome Research, 15, 137–145.
(2004). Functional interaction in establishment of ribosomal integrity between small subunit protein RPS6 and translational regulator RPL10/GRC5p. FEMS Yeast Research, 5, 271–280.
(2006). Searching for ways out of the autism maze: Genetic, epigenetic and environmental clues. Trends in Neuroscience, 29, 349–358.
(2009). Functional impact of global rare copy number variation in autism spectrum disorders. Nature, 466, 368–872.
(2005). Epigenetic overlap in autism-spectrum neurodevelopmental disorders: Mecp2 deficiency causes reduced expression of UBE3A and GABRB3. Human Molecular Genetics, 14, 483–492.
(2004). Phenotypic manifestations of MECP2 mutations in classical and atypical Rett syndrome. American Journal of Medical Genetics, Part A(126A), 129–140.
(2007). Strong association of de novo copy number mutations with autism. Science, 316, 445–449.
(2004). MECP2 structural and 3’-UTR variants in schizophrenia, autism and other psychiatric diseases: A possible association with autism. American Journal of Medical Genetics, Part B(128B), 50–53.
(2005). Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Research, 15, 1034–1050.
(2007). Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nature Genetics, 39, 319–328.
(1994). Fmr1 knockout mice: A model to study fragile × mental retardation. Cell, 78, 23–33.
. (2006). Neuroligins determine synapse maturation and function. Neuron, 51, 741–754.
(2005). Genetic linkage analysis of the X chromosome in autism, with emphasis on the Fragile X region. Psychiatric Genetics, 15, 83–90.
(2009). Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature, 459, 528–533.
(2009). A genome-wide linkage and association scan reveals novel loci for autism. Nature, 461, 802–808.
(2008). Association between microdeletion and microduplication at 16p11.2 and autism. New England Journal of Medicine, 358, 667–675.
(2003). Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. Journal of Medical Genetics, 40, 575–584.
(